In the latent pro-form of matrix metalloproteinase 7 (MMP-7), the cysteine residue in the pro-peptide binds the active-site zinc ion. Hence, recombinant active MMP-7 was prepared from pro-MMP-7 by modification of this cysteine residue with a mercuric reagent. In this study, mature MMP-7 was expressed in Escherichia coli as inclusion bodies, solubilized, and refolded with 1 M L-arginine. The purified product was indistinguishable from the one prepared from pro-MMP-7 as assessed by hydrolysis of (7-methoxycoumarin-4-yl)acetyl-L-Pro-
Human matrix metalloproteinase 7 (MMP-7, matrilysin) [EC 3.4.24 .23] is the smallest matrix metalloproteinase (MMP). It lacks the carboxy-terminal hemopexinlike domain conserved in common MMPs. It is believed to play an important role in tumor invasion and metastasis. 1, 2) It contains a zinc ion essential for activity and other zinc and calcium ions that are considered necessary for stability.
3) Like all other MMPs, it has the consensus sequence HEXXHXXGXXH, in which three histidine residues chelate an active-site zinc ion, and a methionine-containing turn (Met-turn). It exhibits a broad bell-shaped pH-dependence with pK e values of about 4 and 10, indicating that at least two ionizable groups are involved in the catalytic mechanism. [4] [5] [6] [7] An efficient production method for recombinant human MMP-7 is necessary for basic study of this enzyme and the development of inhibitors. MMP-7 is synthesized as an inactive preproenzyme (267 amino acid residues) including 17 residues in the pre-peptide and 77 residues in the pro-peptide. The pro-peptide domain contains a single cysteine residue (Cys70), which binds the active-site zinc ion and renders pro-MMP-7 inactive. This mechanism is called the cysteineswitch mechanism of activation. 8) Under physiological conditions, the pro-form (28 kDa) is activated into the mature form (19 kDa) automatically by cleavage of the peptide bond linking Glu77 and Tyr78 (the numbering of amino acid residues of pro-MMP-7 is applied to mature MMP-7 beginning at the N-terminal Tyr78). In the production of recombinant MMP-7, pro-MMP-7 is expressed in E. coli as inclusion bodies, solubilized, and refolded. Refolded pro-MMP-7 is then converted to mature MMP-7 by modification of Cys70 with a mercuric reagent, such as p-aminophenylmercuric acetate. 9, 10) The drawback of this method is that mercuric reagent is dangerous and their disposal is strictly regulated.
Generally, the pro-domain of protease acts as a molecular chaperone, and is sometimes necessary to produce a recombinant catalytically active enzyme. Both pro-and mature forms of MMPs are expressed in E. coli for this purpose.
11) Cha et al. expressed mature human MMP-7 in E. coli as inclusion bodies, from which the recombinant protein was solubilized with 4 M guanidine HCl and refolded by dialysis to remove guanidine HCl, but the activity (k cat =K m ) of this product was about 50% of that of the one produced from pro-MMP-7. 6) We have reported that of various additives, arginine is the most effective at suppressing protein aggregation during the refolding process of pro-MMP-7.
10) Today, arginine is widely used in the refolding of proteins. 12, 13) This is explained by its affinity for the aromatic groups present in proteins. 13) In this study, we used arginine in the refolding process of mature MMP-7 expressed in E. coli.
The expression plasmid for mature MMP-7 (pET-MMP-7) was constructed by the insertion of amplified MMP-7 DNA into the NdeI and EcoRI sites of pET22b(+) (Merck, Tokyo). As shown in Fig. 1A , pET-MMP-7 contains initiator codon ATG followed by a DNA sequence encoding the mature sequence (Tyr78-Lys250) and stop codon TAG. BL21(DE3) cells were transformed with pET-MMP-7. Ampicillin was used at 50 mg/ml. For seed culture, 2 ml of L broth was inoculated with glycerol stock of the transformants and 
grown with shaking at 37 C for 8 h. The culture was then diluted 1:100 in 200 ml of L broth and grown with shaking. After IPTG induction, growth was continued for 16 h. The cells were harvested by centrifugation (5;000 Â g, 30 min), and suspended with 1 M sucrose. After centrifugation, the pellet was suspended with 10 ml of 20 mM Tris-HCl (pH 7.5), 200 mM NaCl, 10% sucrose, 1 mM EDTA, and 0.5% Triton X-100. This step was repeated once. After centrifugation, the pellet was suspended with 20 ml of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.5 mM PMSF, and 0.1 mg/ml lysozyme, and disrupted by sonication. The lysate was centrifuged (10;000 Â g, 30 min) and the pellet was collected. The inclusion body preparation thus obtained was solubilized with 10-20 volumes of 0.1 M Tris-HCl, 6 M guanidine HCl, and 0.1 M DTT at pH 7.5 with stirring overnight at 25 C. The solution was diluted with 100 volumes of refolding buffer (50 mM Tris-HCl, 10 mM CaCl 2 , 0.1 mM Zn(CH 3 COO) 2 , and 1.0 M Larginine at pH 7.5), and left for 4 h at 4
C. MMP-7 activity hydrolyzing MOCAc-PLGL(Dpa)AR was detected in this diluted solution, indicating that MMP-7 was refolded from inclusion bodies. When refolding buffer without L-arginine was used, no activity was detected (data not shown). Saturated ammonium sulfate solution was added to the refolded solution to a final concentration of 20% saturation. After centrifugation, solid ammonium sulfate was added to the supernatant to a final concentration of 60% saturation. After centrifugation, the pellet was dissolved in 50 mM HEPES buffer (pH 7.5), 10 mM CaCl 2 , and 0.05% v/v Brij-35 (buffer A) at 4 C, and dialyzed against the same buffer. The solution was applied to the column (10 mm inner diameter Â 45 mm) packed with a heparin agarose (Sigma, St. Louis, MO) equilibrated with buffer A. The fractions containing MMP-7 were eluted with buffer A, containing 1.0 M NaCl, and collected. The MMP-7 concentration was determined spectrophotometrically using a molar absorption coefficient at 280 nm, " 280 , of 31,800 M À1 cm À1 . 5) Starting with 100 ml of culture, about 2 mg of purified MMP-7 was recovered. On SDS-PAGE under reducing conditions, the MMP-7 preparation thus obtained yielded a single band with a molecular mass of 19 kDa (Fig. 1B) . NH 2 -terminal sequence determination by Edman degradation revealed that it lacked the expected three N-terminal amino acid residues, Met-Tyr-Ser, which is coincident with a previous report by Cha et al. 6) that denatured MMP-7 during the refolding process had the expected Nterminal sequence of Met-Tyr-Ser-Leu-Phe, while the correctly refolded one lacked three N-terminal amino acids, Met-Tyr-Ser. It is thought that Met-Tyr-Ser was cleaved during the purification process.
The pH-activity profiles as between the MMP-7 produced by the present method and that produced from pro-MMP- 7 10) were compared. MOCAc-PLGL(Dpa)AR (lot 491214) and MOCAc-PLG (lot 510913) were purchased from the Peptide Institute (Osaka). Their concentrations were determined using " 410 ¼ 7:5 mM À1 cm À1 and " 324 ¼ 12:9 mM À1 cm À1 respectively.
14)
The reaction was performed at 25 C by mixing 1,222 ml of the reaction buffer, 20 ml of the enzyme solution, and 8 ml of 234 mM MOCAc-PLGL(Dpa)AR dissolved in DMSO. The reaction buffers were 50 mM acetate-NaOH buffer at pH 3.6-5.8, 50 mM MES-NaOH buffer at pH 5.6-7.0, 50 mM HEPES-NaOH buffer at pH 6.8-8.6, and 50 mM AMPSO-NaOH buffer at pH 8.6-10.4, each containing 10 mM CaCl 2 . The reaction was measured by following the increase in the fluorescence intensity at 393 nm with excitation at 328 nm with a JASCO FP-777 fluorescence spectrophotometer (Tokyo). The peptide bond of the Gly-L-Leu residues was cleaved by MMP-7, and the amount of the product, MOCAc-PLG, was estimated by the fluorescence intensity in comparison with the fluorescence intensity of an authentic MOCAc-PLG solution. Hydrolysis was carried out under pseudo first-order conditions, where the initial concentration of MOCAc-PLGL(Dpa)AR (1.5 mM) was much lower than K m (60 mM).
15) The Michaelis-Menten equation was expressed as
and [S]
o are the initial reaction rate, the molecular activity, the initial enzyme concentration, and the initial substrate concentration respectively. The kinetic parameters, the intrinsic k cat =K m , [ðk cat =K m Þ o ], and the proton dissociation constants (K e1 and K e2 ) for the pH-dependence of the activity were calculated from Eq. (1) by the non-linear least squares regression method with Kaleida Graph Version 3.5 (Synergy Software, Essex, VT): We and others have reported the catalytic mechanism of MMP-7, 4-7) inhibition of MMP-7 activity by alcohols, 15) green tea catechins, 16) and lignans, 17) and the activation of MMP-7 activity by neutral salts.
18) The present production method is useful for site-directed mutagenesis experiments on MMP-7, which is currently under way to clarify the mechanisms. The present results also suggest the usefulness of L-arginine as an additive in the refolding process of proteins, which is done by trial and errors in most cases. MOCAc-PLGL(Dpa)AR at 25 C. The initial enzyme and substrate concentrations were 11.4 nM and 1.5 mM respectively for the MMP-7 produced by the present method (open circle) and 6.3 nM and 1.5 mM respectively for the one produced from pro-MMP-7 (closed circle). The v max values, which are the reaction rates at optimal pH levels, were 2.1 nM/s at pH 7.5 for the former MMP-7 and 1.5 nM/s at pH 7.5 for the latter. Solid and broken lines represent the best fit to Eq. (1).
